New findings highlight clinician-level variation in lipid management for secondary ASCVD prevention, revealing opportunities to standardize care and improve outcomes.
🔗 https://ow.ly/7swS50Y8VHm

#LipidManagement #ASCVD #PreventiveCardiology #PracticeImprovement #CardioSky #MedSky

New retrospective cohort study compares low-intensity vs. moderate-to-high-intensity lipid-lowering therapy after MI in patients aged 80+—shedding light on treatment intensity and outcomes in older adults.

🔗 https://ow.ly/ZW5m50XUfvu

#LipidManagement #MedSky #PreventiveCardiology #CardioSky

Poland is emerging as a leader in Europe for effective lipid disorders management programmes—highlighting innovative strategies, improved diagnostics, and stronger care pathways across the country.
🔗 https://ow.ly/qhLr50XrlkA

#LipidManagement #CardioPrevention #EuropeHealth #CardioSky #MedSky

🩺 Managing Primary Dyslipidemia in a 49F with LDL 138 mg/dL & FHx of premature MI.
Moderate ASCVD risk→ Start Atorvastatin 10 mg + lifestyle.
🎯 Goal: LDL <100 mg/dL
🔍 Aligned with 2023–24 ESC, ACC, ICMR, WHO guidelines.
#Medical #PrimaryPrevention #LipidManagement #Statins #EvidenceBasedMedicine

🚨Lipid Panel happening NEXT week, May 20 @ 8pm ET!

Join top clinical pharmacists as they break down what every clinician should know about pharmacology in lipid management.

🌟Don’t miss it! Register at lipid.org/thelipidpanel

#LipidPanel #Pharmacology #LipidManagement #CME

🆕 New from the International Atherosclerosis Society: Strategies to improve care for familial hypercholesterolemia through implementation science.

Next steps to close the care gap.

🔗 ow.ly/huKo50VAsE0

#FH #ImplementationScience #LipidManagement #Cardiology #ASPC #CardioSky #MedSky